Ustekinumab Exposure-outcome Analysis in Crohn’s Disease Only in Part Explains Limited Endoscopic Remission Rates

Bram Verstockt, Marc Ferrante, Maja Noman et al.|Journal of Crohn s and Colitis|2019

Cited by 123